ALX ONCOLOGY HOLDINGS INC (ALXO) › Cash & EquivalentsALX ONCOLOGY HOLDINGS INC (ALXO) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2019-12-31: $9.02M2020-12-31: $434.22M2021-12-31: $363.67M2022-12-31: $48.82M2023-12-31: $22.41M2024-12-31: $17.57M2025-12-31: $16.37M$16.37M2019-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$16.37M-6.8%2026-03-09Balance as of period end2024-12-31$17.57M-21.6%2026-03-09Balance as of period end2023-12-31$22.41M-54.1%2026-03-09Balance as of period end2022-12-31$48.82M-86.6%2025-03-06Balance as of period end2021-12-31$363.67M-16.2%2024-03-07Balance as of period end2020-12-31$434.22M+4715.6%2023-03-09Balance as of period end2019-12-31$9.02M—2021-03-18Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)